Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CannRx Oncology Support Formulation is a preclinical cannabis-based formulation being developed by CannRx Technology for oncology support and cancer supportive care. Based on the company pipeline description, it appears to be part of CannRx Technology's broader cannabinoid formulation platform, which uses a nanoparticle water-soluble delivery approach for cannabinoids and terpenes; however, no product-specific active ingredients, molecular targets, dosage form, route of administration, or detailed pharmacology have been publicly disclosed for this oncology-support candidate. Its intended role is supportive care in patients with cancer rather than direct antitumor treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CannRx Oncology Support Formulation.